questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiologiques respiratoires
Capacité pulmonaire totale
Capacité vitale
Capacité vitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Spirométrie
Fonction pulmonaire
Pléthysmographie
Gaz du sang
Capacité vitale
Normes physiologiques
Dyspnée
Maladies pulmonaires
Symptômes
5
Essoufflement
Oppression thoracique
Douleurs thoraciques
Cyanose
Âge
Dégradation pulmonaire
Prévention
5
Tabagisme
Activité physique
Vaccins
Infections respiratoires
Exercice physique
Fonction pulmonaire
Hydratation
Voies respiratoires
Traitements
5
Réhabilitation pulmonaire
Bronchodilatateurs
Physiothérapie
Fonction pulmonaire
Médicaments
Bronchodilatateurs
Complications
5
Insuffisance respiratoire
Infections pulmonaires
Capacité vitale
Complications respiratoires
Maladies cardiaques
Capacité vitale
Infections pulmonaires
Inflammation
Effets à long terme
Santé respiratoire
Facteurs de risque
5
Âge
Dégradation pulmonaire
Environnement de travail
Pollution
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité vitale : Questions médicales les plus fréquentes",
"headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité vitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Capacité pulmonaire totale",
"url": "https://questionsmedicales.fr/mesh/D014109",
"about": {
"@type": "MedicalCondition",
"name": "Capacité pulmonaire totale",
"code": {
"@type": "MedicalCode",
"code": "D014109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve expiratoire",
"alternateName": "Expiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D005105",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve expiratoire",
"code": {
"@type": "MedicalCode",
"code": "D005105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Capacité inspiratoire",
"alternateName": "Inspiratory Capacity",
"url": "https://questionsmedicales.fr/mesh/D007320",
"about": {
"@type": "MedicalCondition",
"name": "Capacité inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve inspiratoire",
"alternateName": "Inspiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D007321",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Volume courant",
"alternateName": "Tidal Volume",
"url": "https://questionsmedicales.fr/mesh/D013990",
"about": {
"@type": "MedicalCondition",
"name": "Volume courant",
"code": {
"@type": "MedicalCode",
"code": "D013990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Capacité vitale",
"alternateName": "Vital Capacity",
"code": {
"@type": "MedicalCode",
"code": "D014797",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Toby M Maher",
"url": "https://questionsmedicales.fr/author/Toby%20M%20Maher",
"affiliation": {
"@type": "Organization",
"name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA."
}
},
{
"@type": "Person",
"name": "Hyun Lee",
"url": "https://questionsmedicales.fr/author/Hyun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Hye Yun Park",
"url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Masato Kono",
"url": "https://questionsmedicales.fr/author/Masato%20Kono",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36175812",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10096-022-04500-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36496283",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2022.11.075"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transmission factors and exposure to infections at work and invasive pneumococcal disease.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36385261",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ajim.23439"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35763298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2022.18959"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Vaccinations in pulmonary diseases - part 2: herpes zoste, RSV, pneumococcal infection and pertussis].",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39437831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2372-1157"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012143"
},
{
"@type": "ListItem",
"position": 4,
"name": "Capacité pulmonaire totale",
"item": "https://questionsmedicales.fr/mesh/D014109"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité vitale",
"item": "https://questionsmedicales.fr/mesh/D014797"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité vitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité vitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité vitale",
"description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité vitale",
"description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité vitale",
"description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité vitale",
"description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité vitale",
"description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité vitale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Pneumococcal+Infections#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité vitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests complètent l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères normaux de capacité vitale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L."
}
},
{
"@type": "Question",
"name": "Quand suspecter une capacité vitale réduite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème pulmonaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une capacité vitale faible ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique."
}
},
{
"@type": "Question",
"name": "La toux est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la réduction de la capacité vitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certaines expositions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire."
}
},
{
"@type": "Question",
"name": "L'hydratation est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent la capacité vitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle utile ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la cause ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "La capacité vitale faible augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les infections affectent-elles la capacité vitale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la capacité vitale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne."
}
},
{
"@type": "Question",
"name": "L'environnement de travail est-il un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Imperial College London, London, UK.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
University of California San Francisco, 8785, San Francisco, California, United States.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium; Department of Geriatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: ivan.bautmans@vub.be.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Ageing and Health Unit, WHO, Geneva, Switzerland.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, Australia; Yong Loo Lin School of Medicine, Centre for Healthy Longevity, National University of Singapore, Singapore; National University Health System, Singapore.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Institute for Biomedicine of Aging, University of Erlangen-Nuremberg, Nuremberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Faculty of Sciences, Department of Exercise Sciences, Université du Québec à Montréal, QC, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Weill Cornell Medicine, New York, New York, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019,...
To examine rates of serious pneumococcal infections up to 10 years after vaccination with 7-valent conjugated pneumococcal vaccine (PCV7) in patients with arthritis compared to non-vaccinated arthriti...
In total, 595 adult arthritis patients (rheumatoid arthritis; RA = 342, 80 % women and spondylarthropathy; SpA = 253, 45 % women) received one dose of PCV7. Mean age/disease duration were 62/16 and 51...
Among vaccinated RA and SpA patients, there was a significant relative risk reduction of pneumonia and all serious infections; 53% and 46%, respectively. There was no significant difference in time to...
One dose of pneumococcal conjugate vaccine may decrease risk of serious pneumococcal infection up to 10 years in patients with arthritis receiving immunomodulating treatment....
Working in close contacts with coworkers or the general public may be associated with transmission of invasive pneumococcal disease (IPD). We investigated whether crowded workplaces, sharing surfaces,...
We studied 3,968 cases of IPD, and selected six controls for each case from the Swedish population registry with each control being assigned the index date of their corresponding case. We linked job h...
ORs for IPD for the different transmission dimensions were increased moderately but were statistically significant. Compared to home-working or working alone, the highest odds was for Working mostly o...
IPD was associated with working in close contact with coworkers or the general public, and with outside work, especially for men. Contact with infected patients or persons was not associated with IPD....
An association between pneumococcal nasopharyngeal carriage and invasive pneumococcal disease (IPD) has been previously established. However, it is unclear whether the decrease in IPD incidence observ...
To assess changes in IPD incidence after the implementation of NPIs during the COVID-19 pandemic and examine their temporal association with changes in pneumococcal carriage rate and respiratory viral...
This cohort study used interrupted time series analysis of data from ambulatory and hospital-based national continuous surveillance systems of pneumococcal carriage, RSV and influenza-related diseases...
Implementation of NPIs during the COVID-19 pandemic....
The estimated fraction of IPD change after implementation of NPIs and the association of this change with concomitant changes in pneumococcal carriage rate and RSV and influenza cases among children y...
During the study period, 5113 children (median [IQR] age, 1.0 [0.6-4.0] years; 2959 boys [57.9%]) had IPD, and 6831 healthy children (median [IQR] age, 1.5 [0.9-3.9] years; 3534 boys [51.7%]) received...
In this cohort study of data from multiple national continuous surveillance systems, a decrease in pediatric IPD incidence occurred after the implementation of NPIs in France; this decrease was associ...
RSV is a common cause of respiratory tract infections, posing a risk of severe disease, particularly for newborns and infants, as well as in older individuals with pre-existing conditions. Two safe an...
Although viewed primarily as a childhood disease, the majority of infections affect adults. Patients with chronic respiratory diseases are at a higher risk for severe clinical course of pertussis infe...
Herpes Zoster (shingles) is caused by the varicella-zoster virus, and reactivations can lead to painful skin lesions and potential complications such as herpes zoster oticus, meningitis, or postherpet...
Pneumococcus remains a major cause of adult lower respiratory tract infections (LRTI). Few data exist on the relative contribution of serotypes included in pneumococcal vaccines to community-acquired ...
A prospective cohort study at two Bristol hospitals (UK) including all adults age ≥ 18-years hospitalised with acute lower respiratory tract disease (aLRTD) from Nov2021-Nov2022. LRTI patients were cl...
Of 12,083 aLRTD admissions, 10,026 had LRTI and 2,445 provided urine: 1,097 CAP + RAD+; 207 CAP + RAD-; and 1,141 NP-LRTI. Median age was 71.1y (IQR57.9-80.2) and Charlson comorbidity index = 4 (IQR2-...
Among adults hospitalised with respiratory infection, pneumococcus is an important pathogen across all subgroups, including CAP+/RAD- and NP-LRTI. Despite 20-years of PPV23 use in adults ≥ 65-years an...
Streptococcus pneumoniae (the pneumococcus) is the major cause of bacterial pneumonia in the US and worldwide. Studies have shown that the differing chemical make-up between serotypes of its most impo...
Pneumococcal conjugate vaccines (PCVs) protect against invasive pneumococcal disease (IPD) among vaccinees. However, at population level, this protection is driven by indirect effects. PCVs prevent na...
The 23 French Regional Pneumococcal Observatories (ORPs) analyzed antibiotic resistance and serotypes of Streptococcus pneumoniae strains isolated from invasive infections in France over a 12-year per...
Between 2009 and 2021, the ORPs analyzed 19,319 strains, including 1,965 in children and 17,354 in adults. Strains were assessed for their resistance to penicillin G, amoxicillin and cefotaxime. Serot...
During this period, the number of strains collected yearly decreased significantly. The decrease was particularly pronounced up until 2013, especially in children (-61.0%). However, penicillin non-sus...
During the study period, data collected by the network highlighted an increase of invasive PNSPs in children and non-vaccine serotypes. Surveillance of resistance and serotypes remains instrumental, p...
Following the introduction of pneumococcal conjugate vaccines (PCVs), the rate of invasive pneumococcal disease (IPD) declined, however, IPDs replaced by serotypes that are not included in the vaccine...